Melissa Brouwers, McMaster University
Associate Professor
Oncology
Hamilton, Ontario
mbrouwer@mcmaster.ca
Office:
(905) 525-9140 ext. 22527
Expert In
Bio/Research
Dr. Melissa Brouwers is an Associate Professor and Head, Health Services Research in the Department of Oncology, McMaster University; the Provincial Director of the Program in Evidence-based Care, Cancer Care Ontario and the Project Lead for the Capacity Enhancement Project of the Canadian Partne...
Click to Expand >>
Click to Expand >>
Bio/Research
Dr. Melissa Brouwers is an Associate Professor and Head, Health Services Research in the Department of Oncology, McMaster University; the Provincial Director of the Program in Evidence-based Care, Cancer Care Ontario and the Project Lead for the Capacity Enhancement Project of the Canadian Partnership Against Cancer Corporation. She holds a B.Sc. in Psychology from the University of Toronto and an MA and PhD in Psychology from the University of Western Ontario.
In addition to her work with the PEBC and the CEP, Dr. Brouwers holds an additional $4.7M in funding from CIHR as a principal investigator and co-investigator.Of particular note, Dr. Brouwers has been a world leader in advancing the gold standard of guideline development, reporting and appraisal as the Principal Investigator of the CIHR-supported international research team the AGREE Next Steps Consortium (see www. agreetrust.com). Just completing two randomized controlled trials and additional studies, Dr. Brouwers and the Consortium is set to release AGREE 2.0, the new international standard, in Spring 2009.
She is a member of the Clinical Guidelines (CG) Action Group of the Canadian Partnership Against Cancer Corporation (CPACC), and the former Lead of the Health Technology Utilization Guidelines of Ontario (Health TUGO). She is also a member of the KT-ICEBeRG team and McMaster University's Collaboration for Health KT Stream. She holds several peer review funded grants both as a principal investigator and co-investigator.
Melissa's primary research interests include the development, dissemination, implementation and evaluation of evidence-based decisions products such as clinical practice guidelines, standards, and quality indicators, models of decision-making, and knowledge translation and/or brokering. Her teaching interests include research methods, behaviour sciences and social sciences.
Click to Shrink <<
In addition to her work with the PEBC and the CEP, Dr. Brouwers holds an additional $4.7M in funding from CIHR as a principal investigator and co-investigator.Of particular note, Dr. Brouwers has been a world leader in advancing the gold standard of guideline development, reporting and appraisal as the Principal Investigator of the CIHR-supported international research team the AGREE Next Steps Consortium (see www. agreetrust.com). Just completing two randomized controlled trials and additional studies, Dr. Brouwers and the Consortium is set to release AGREE 2.0, the new international standard, in Spring 2009.
She is a member of the Clinical Guidelines (CG) Action Group of the Canadian Partnership Against Cancer Corporation (CPACC), and the former Lead of the Health Technology Utilization Guidelines of Ontario (Health TUGO). She is also a member of the KT-ICEBeRG team and McMaster University's Collaboration for Health KT Stream. She holds several peer review funded grants both as a principal investigator and co-investigator.
Melissa's primary research interests include the development, dissemination, implementation and evaluation of evidence-based decisions products such as clinical practice guidelines, standards, and quality indicators, models of decision-making, and knowledge translation and/or brokering. Her teaching interests include research methods, behaviour sciences and social sciences.
Click to Shrink <<